Cannabis Law Report

JULY 19, 2021

There is an urgent need for objective, scientifically sound and robust clinical trials to support medicinal cannabis and psychedelics (psilocybin, MDMA, LSD, Ketamine). Collectively, between the two organizations we offer a full-service package from protocol development to timely and successful clinical trial execution.”.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Veriheal

MARCH 20, 2023

Johns Hopkins University first received regulatory approval for psychedelic research in the year 2000. While decriminalization decreases the negative impact of legal issues, it does not provide accessible, safe, and regulated psilocybin for those seeking treatment. California Massachusetts Michigan Washington Washington, D.C.

Clinical Trials 98

Clinical Trials Therapy Decriminalization Treatment 98

Cannabis Law Report

JANUARY 4, 2022

“I am so very proud of all Anebulo has achieved over the past 18 months, including building out a highly effective team, securing new intellectual property protection, preparing and starting a proof-of-concept clinical trial, advancing regulatory discussions with the U.S. and Australia.

Pharmaceutical 52

Pharmaceutical Research and Development Clinical Trials Cannabinoids 52

Otherside Farms

JANUARY 23, 2019

Medscape: Medscape Access. full – 2000). abst – 2000). 2000] – PubMed result. 2000] – PubMed result. Marijuana’s Active Ingredient Targets Deadly Brain Cancer (news – 2000). Pot Shrinks Tumors; Government Knew in ’74 (news – 2000). full – 2000).

Cannabinoids 72

Cannabinoids Treatment Therapy Research and Development 72

The Cannigma

OCTOBER 27, 2021

to 2000 mg/kg of THC or 5000 mg/kg of crude marihuana extract (CME). They were 7-10 months old and weighed 6-13 kg, which means that according to the math, some of those dogs may have consumed as much as 26,000 mg of THC (if they were 13 kilograms and were given 2000 mg/kg of THC). The beagles were also given giant doses of 65.6

THC 144

THC Research and Development Clinical Trials Cannabinoids 144

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. For over three decades, we’ve been working to achieve mass mental health throughout the United States, Canada, and Europe.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

NOVEMBER 24, 2021

However, the nature of the government regulations and the subsequent complexity of prescribing, as well as doctors’ safety uncertainties and the stigma of the plant, remain contributing barriers to patient access. Patients can legally access medicinal cannabis through a doctor, via the TGA’s Authorised Prescribers and Special Access schemes.

Research and Development 52

Research and Development Medicine Access Media 52